We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

159 hedge funds and large institutions have $1.02B invested in Taro Pharmaceutical Industries Ltd. in 2016 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 84 increasing their positions, 33 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

485% more call options, than puts

Call options by funds: $6.99M | Put options by funds: $1.19M

155% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 33

24% more capital invested

Capital invested by funds: $826M → $1.02B (+$199M)

5% less funds holding

Funds holding: 167 → 159 (-8)

16% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 31

38% less funds holding in top 10

Funds holding in top 10: 8 → 5 (-3)

Holders
159
Holders Change
-8
Holders Change %
-4.79%
% of All Funds
4.24%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.13%
New
26
Increased
84
Reduced
33
Closed
31
Calls
$6.99M
Puts
$1.19M
Net Calls
+$5.79M
Net Calls Change
+$6.04M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$40.6M
2
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$20.1M
3
Renaissance Technologies
Renaissance Technologies
New York
+$18.4M
4
BIT
BlackRock Institutional Trust
California
+$15.2M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$14.9M

Top Sellers

1
GCM
Greywolf Capital Management
New York
-$35.1M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$8.62M
3
GPC
Guardian Point Capital
Virginia
-$7.16M
4
Morgan Stanley
Morgan Stanley
New York
-$5.21M
5
AL
AJO LP
Pennsylvania
-$4.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Teacher Retirement System of Texas
76
Teacher Retirement System of Texas
Texas
$1.22M -$858K -6,051 -42%
CIBC Asset Management
77
CIBC Asset Management
Ontario, Canada
$1.18M -$1.36M -9,625 -54%
SG Americas Securities
78
SG Americas Securities
New York
$1.16M -$55.3K -390 -5%
SG
79
Societe Generale
$1.16M +$1.13M +7,940 New
D.E. Shaw & Co
80
D.E. Shaw & Co
New York
$1.15M -$193K -1,359 -15%
TU
81
TDAM USA
Ontario, Canada
$1.06M -$80.8K -570 -7%
UBS Group
82
UBS Group
Switzerland
$1.05M +$722K +5,092 +238%
Manulife (Manufacturers Life Insurance)
83
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.05M +$539K +3,800 +112%
Creative Planning
84
Creative Planning
Kansas
$1.02M +$425K +3,000 +75%
AP
85
AHL Partners
United Kingdom
$995K +$238K +1,681 +33%
SCA
86
Snowden Capital Advisors
New York
$980K +$45.7K +322 +5%
Prudential Financial
87
Prudential Financial
New Jersey
$931K +$104K +730 +13%
Mackenzie Financial
88
Mackenzie Financial
Ontario, Canada
$892K – – –
US Bancorp
89
US Bancorp
Minnesota
$824K +$10.1K +71 +1%
ASN
90
Advisory Services Network
Georgia
$803K +$1.42K +10 +0.2%
AllianceBernstein
91
AllianceBernstein
Tennessee
$756K -$8.62M -60,801 -92%
Invesco
92
Invesco
Georgia
$745K -$22K -155 -3%
Connor, Clark & Lunn Investment Management (CC&L)
93
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$743K +$723K +5,100 New
AQR Capital Management
94
AQR Capital Management
Connecticut
$707K +$117K +826 +21%
SCM
95
Sterling Capital Management
North Carolina
$677K +$659K +4,650 New
Stifel Financial
96
Stifel Financial
Missouri
$653K +$635K +4,480 New
Jane Street
97
Jane Street
New York
$586K +$5.11K +36 +0.9%
TD Asset Management
98
TD Asset Management
Ontario, Canada
$553K – – –
BNP Paribas Financial Markets
99
BNP Paribas Financial Markets
France
$533K -$39.3K -277 -7%
PP
100
Paloma Partners
Connecticut
$518K +$505K +3,558 New
2 3
4
5 6

TARO Hedge Fund Activity: Q2 2016 in Review

159 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2016, worth a combined $1.02B — up 24% from $826M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of TARO and 26 opened new positions — a net loss of 5 holders — while 33 trimmed existing stakes and 84 added.

The largest buyer was Goldman Sachs, adding an estimated $40.6M. The largest seller was Greywolf Capital Management, exiting entirely with an estimated $35.1M sold.

  • 159 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2016, down from 167 in Q1 2016.
  • Funds reported $1.02B of Taro Pharmaceutical Industries Ltd. stock for Q2 2016, up 24% quarter-over-quarter.
  • 26 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2016 and 31 closed out, a net change of -5 holders.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2016 was Goldman Sachs, an estimated $40.6M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2016 was Greywolf Capital Management, an estimated $35.1M sold.

Based on aggregated 13F filings for Q2 2016.